Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Upexi, Inc. (UPXI:NASDAQ), powered by AI.
Upexi, Inc. is currently trading at $0.97. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Upexi, Inc. on Alpha Lenz.
Upexi, Inc.'s P/E ratio is -0.6.
“Upexi, Inc. trades at a P/E of -0.6 (undervalued) with modest ROE of -28.3%.”
Ask for details →Upexi, Inc. is a diversified brand owner specializing in the development, manufacturing, and distribution of consumer products across multiple industries. The company's portfolio includes products in the pet care sector, such as nail grinders and all-natural supplements under the LuckyTail brand, as well as functional mushrooms (Cure Mushrooms), energy solutions (PRAX), craft cannabinoid goods (Moonwlkr), and gummies and wellness items (Gumi Labs). Upexi serves its markets through a mix of direct-to-consumer platforms, wholesale relationships, and third-party e-commerce channels. Notably, the company leverages in-house programmatic advertising technology to optimize marketing spend and derive data-driven insights for cross-brand promotions. In addition to its core consumer product operations, Upexi has expanded into the cryptocurrency and asset management space. Established in 2018 and headquartered in Tampa, Florida, Upexi, Inc. plays a strategic role in bringing innovative consumer solutions to diverse markets while pursuing efficiencies through vertical integration and digital commerce aggregation.
“Upexi, Inc. trades at a P/E of -0.6 (undervalued) with modest ROE of -28.3%.”
Ask for details →